News & Updates

In persons living with HIV (PLHIV) with anal high-grade squamous intraepithelial lesions (HSIL), treatment of the lesions reduced the risk of progression to anal cancer compared with active monitoring, the phase III ANCHOR* trial has shown.

In patients undergoing laparoscopic hysteromyomectomy, intraoperative intravenous use of dexmedetomidine may help ease postoperative ileus, hastening the recovery of gastrointestinal (GI) function after operation, according to a recent study.

New drug applications approved by US FDA as of 16 - 31 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of estrogen replacement therapy appears to yield a risk-lowering effect on gastric and colorectal cancers, as reported in a retrospective study.

Several adult patients with eosinophilic esophagitis (EoE) poorly adhere to their maintenance treatment, a recent study has found.